A high degree of heterogeneity is seen in the care of men with penile cancer around the world, stated Philippe E. Spiess, MD, Associate Member of the Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, and a member of the NCCN Panel on bladder and penile cancers. With the use of non–evidence-based treatment approaches, outcomes can widely vary. To clarify some of the controversies associated with the treatment of penile cancer, NCCN has created inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for penile cancer, with input from experts in penile cancer from around the world. This comprehensive protocol is intended to establish a foundation to help standardize and optimize the care of patients faced with this potentially disfiguring and lethal cancer.
AlnajjarHMLamWBolgeriM. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol2012;62:923–928.
FeldmanASMcDougalWS. Long-term outcome of excisional organ sparing surgery for carcinoma of the penis. J Urol2011;186:1303–1307.
FicarraVZattoniFArtibaniW. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol2006;175:1700–1704.
TanisPJLontAPMeinhardtW. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol2002;168:76–80.
SpiessPEIzawaJIBassettR. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol2007;177:2157–2161.
PagliaroLCWilliamsDLDalianiD. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol2010;28:3851–3857.
LeijteJAKirranderPAntoniniN. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol2008;54:161–168.
GraaflandNMMoonenLMvan BovenHH. Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J Urol2011;185:888–893.